Imaging of Inherited Metabolic and Endocrine Disorders

Area of Science:

• Medical Genetics
• Pediatric Neurology
• Neonatology

Background:

• Inherited metabolic disorders (IMDs) are a significant cause of neonatal illness.
• Approximately 25% of IMDs manifest in the neonatal period with acute, severe symptoms.
• Neonatal presentation often indicates profound metabolic derangement and high risk of adverse outcomes.

Purpose of the Study:

• To review the classification of IMDs presenting in neonates.
• To outline the clinical and imaging findings associated with these disorders.
• To emphasize the importance of rapid diagnosis and management in the neonatal period.

Main Methods:

• Literature review of IMDs with neonatal presentation.
• Synthesis of classification systems for metabolic and endocrine disorders.
• Compilation of characteristic clinical and neuroimaging findings.

Main Results:

• IMDs present a diverse spectrum of clinical manifestations and imaging abnormalities in neonates.
• Early recognition of nonspecific signs is crucial for timely diagnosis.
• Specific diagnostic criteria and imaging patterns aid in identifying affected infants.

Conclusions:

• Neonatal onset IMDs require prompt recognition and intervention to mitigate severe neurological sequelae.
• Understanding the classification and presentation is key for effective clinical management.
• Multidisciplinary approach is essential for optimizing outcomes in affected neonates.